The Accurate Auditor Team
Ozone DOES KILL COVID - Says Japanese Study...!
Updated: Sep 4, 2020
Last week I confidently wrote that "COVID Killers Kill COVID!" While filled with anecdotal and Company evidence, it's nice to have that Blog validated!
This just in! From Reuters, "Japan researchers say ozone effective in neutralising corona virus! This article, dated August 26, 2020, is the perfect referral for the JIMCO MAC500. While not referencing it by name, the "low concentrations" that the article mentions are identical to the MAC500 and OZ1000/2000.
TOKYO (Reuters) - Japanese researchers said on Wednesday that low concentrations of ozone can neutralise coronavirus particles, potentially providing a way for hospitals to disinfect examination rooms and waiting areas.Scientists at Fujita Health University told a news conference they had proven that ozone gas in concentrations of 0.05 to 0.1 parts per million (ppm), levels considered harmless to humans, could kill the virus. The experiment used an ozone generator in a sealed chamber with a sample of coronavirus. The potency of the virus declined by more than 90% when subjected to low level ozone for 10 hours.
“Transmission of the novel coronavirus may be reduced by continuous, low-concentration ozone treatment, even in environments where people are present, using this kind of system,” said lead researcher Takayuki Murata. “We found it to be particularly effective in high-humidity conditions.”
Ozone, a type of oxygen molecule, is known to inactivate many pathogens, and previously
experiments have shown that high concentrations, between 1-6 ppm, were effective against the coronavirus but potentially toxic to humans. A recent study at the Georgia Institute of Technology showed that ozone may be effective in disinfecting gowns, goggles and other medical protective equipment.
Fujita Medical University Hospital, in Aichi prefecture central Japan, has installed ozone
generators to reduce infection in waiting areas and patient rooms.
The university has also performed a clinical trial of Fujifilm Holdings Corp’s (4901.T) Avigan
drug on COVID-19 patients.